ABSTRACT
Smoking burdens are greatest among underserved patients. Lung cancer screening (LCS) reduces mortality among individuals at risk for smoking-associated lung cancer. Although LCS programs must offer smoking cessation support, the interventions that best promote cessation among underserved patients in this setting are unknown. This stakeholder-engaged, pragmatic randomized clinical trial will compare the effectiveness of four interventions promoting smoking cessation among underserved patients referred for LCS. By using an additive study design, all four arms provide standard "ask-advise-refer" care. Arm 2 adds free or subsidized pharmacologic cessation aids, arm 3 adds financial incentives up to $600 for cessation, and arm 4 adds a mobile device-delivered episodic future thinking tool to promote attention to long-term health goals. We hypothesize that smoking abstinence rates will be higher with the addition of each intervention when compared with arm 1. We will enroll 3,200 adults with LCS orders at four U.S. health systems. Eligible patients include those who smoke at least one cigarette daily and self-identify as a member of an underserved group (i.e., is Black or Latinx, is a rural resident, completed a high school education or less, and/or has a household income <200% of the federal poverty line). The primary outcome is biochemically confirmed smoking abstinence sustained through 6 months. Secondary outcomes include abstinence sustained through 12 months, other smoking-related clinical outcomes, and patient-reported outcomes. This pragmatic randomized clinical trial will identify the most effective smoking cessation strategies that LCS programs can implement to reduce smoking burdens affecting underserved populations. Clinical trial registered with clinicaltrials.gov (NCT04798664). Date of registration: March 12, 2021. Date of trial launch: May 17, 2021.
Subject(s)
Lung Neoplasms , Smoking Cessation , Adult , Early Detection of Cancer/methods , Humans , Lung Neoplasms/diagnosis , Lung Neoplasms/prevention & control , Randomized Controlled Trials as Topic , Smoking , Smoking Cessation/methods , Vulnerable PopulationsABSTRACT
Expert recommendations to discuss prognosis and offer palliative options for critically ill patients at high risk of death are variably heeded by intensive care unit (ICU) clinicians. How to best promote such communication to avoid potentially unwanted aggressive care is unknown. The PONDER-ICU (Prognosticating Outcomes and Nudging Decisions with Electronic Records in the ICU) study is a 33-month pragmatic, stepped-wedge cluster randomized trial testing the effectiveness of two electronic health record (EHR) interventions designed to increase ICU clinicians' engagement of critically ill patients at high risk of death and their caregivers in discussions about all treatment options, including care focused on comfort. We hypothesize that the quality of care and patient-centered outcomes can be improved by requiring ICU clinicians to document a functional prognostic estimate (intervention A) and/or to provide justification if they have not offered patients the option of comfort-focused care (intervention B). The trial enrolls all adult patients admitted to 17 ICUs in 10 hospitals in North Carolina with a preexisting life-limiting illness and acute respiratory failure requiring continuous mechanical ventilation for at least 48 hours. Eligibility is determined using a validated algorithm in the EHR. The sequence in which hospitals transition from usual care (control), to intervention A or B and then to combined interventions A + B, is randomly assigned. The primary outcome is hospital length of stay. Secondary outcomes include other clinical outcomes, palliative care process measures, and nurse-assessed quality of dying and death.Clinical trial registered with clinicaltrials.gov (NCT03139838).
Subject(s)
Critical Illness , Intensive Care Units , Adult , Critical Illness/therapy , Electronics , Humans , Palliative Care , Randomized Controlled Trials as Topic , Respiration, ArtificialABSTRACT
Rotations about its three carbon-nitrogen bonds give triethylamine a complex, 3-dimensional potential energy landscape of conformeric structures. Electronic excitation to Rydberg states prepares the molecule in a high-energy, nonequilibrium distribution of such conformers, initiating ultrafast transitions between them. Time-resolved Rydberg electron binding energy spectra, observed using photoionization-photoelectron spectroscopy with ultrashort laser pulses, reveal these time-evolving structures. The time-dependent structural fingerprint spectra are assigned with the aid of a computational analysis of the potential energy landscape. Upon 209 nm electronic excitation to the 3p Rydberg state, triethylamine decays to 3s with a 200 fs time constant. The initially prepared conformer reacts to a mixture of structures with a time constant of 232 fs and settles into a final geometry distribution on a further subpicosecond time scale. The binding energy of the Rydberg electron is found to be an important determinant of the conformeric energy landscape.